Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study

• Hauptverfasser: Chien-Yu Cheng (Verfasst von), Ying-Shih Su (Verfasst von), Chyi-Liang Chen (Verfasst von), Mingi Chang (Verfasst von), Shu-Wei Huang (Verfasst von), Peng-Nien Huang (Verfasst von), Shin-Ru Shih (Verfasst von), Yu-Shen Hsu (Verfasst von), Cheng-Hsun Chiu (Verfasst von)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

The objective of the study was to assess the safety, tolerability, and potential efficacy of intranasally administered AD17002, a detoxified form of Escherichia coli heat-labile enterotoxin, in treating individuals with mild-to-moderate coronavirus disease of 2019 (COVID-19). In this randomized, dou...